000107416 001__ 107416
000107416 005__ 20230519145440.0
000107416 0247_ $$2doi$$a10.3390/ijerph18094872
000107416 0248_ $$2sideral$$a124736
000107416 037__ $$aART-2021-124736
000107416 041__ $$aeng
000107416 100__ $$aMenditto, Enrica
000107416 245__ $$aPersistence as a robust indicator of medication adherence-related quality and performance
000107416 260__ $$c2021
000107416 5060_ $$aAccess copy available to the general public$$fUnrestricted
000107416 5203_ $$aMedication adherence is a priority for health systems worldwide and is widely recognised as a key component of quality of care for disease management. Adherence-related indicators were rarely explicitly included in national health policy agendas. One barrier is the lack of standardised adherence terminology and of routine measures of adherence in clinical practice. This paper discusses the possibility of developing adherence-related performance indicators highlighting the value of measuring persistence as a robust indicator of quality of care. To standardise adherence and persistence-related terminology allowing for benchmarking of adherence strategies, the European Ascertaining Barriers for Compliance (ABC) project proposed a Taxonomy of Adherence in 2012 consisting of three components: initiation, implementation, discontinuation. Persistence, which immediately precedes discontinuation, is a key element of taxonomy, which could capture adherence chronology allowing the examination of patterns of medication-taking behaviour. Advances in eHealth and Information Communication Technology (ICT) could play a major role in providing necessary structures to develop persistence indicators. We propose measuring persistence as an informative and pragmatic measure of medication-taking behaviour. Our view is to develop quality and performance indicators of persistence, which requires investing in ICT solutions enabling healthcare providers to review complete information on patients’ medication-taking patterns, as well as clinical and health outcomes.
000107416 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000107416 590__ $$a4.614$$b2021
000107416 592__ $$a0.814$$b2021
000107416 594__ $$a4.5$$b2021
000107416 591__ $$aPUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH$$b45 / 183 = 0.246$$c2021$$dQ1$$eT1
000107416 593__ $$aPollution$$c2021$$dQ1
000107416 591__ $$aPUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH$$b71 / 210 = 0.338$$c2021$$dQ2$$eT2
000107416 593__ $$aHealth, Toxicology and Mutagenesis$$c2021$$dQ1
000107416 591__ $$aENVIRONMENTAL SCIENCES$$b100 / 279 = 0.358$$c2021$$dQ2$$eT2
000107416 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000107416 700__ $$aCahir, Caitriona
000107416 700__ $$0(orcid)0000-0002-7194-8275$$aMalo, Sara$$uUniversidad de Zaragoza
000107416 700__ $$0(orcid)0000-0001-7293-701X$$aAguilar-Palacio, Isabel$$uUniversidad de Zaragoza
000107416 700__ $$aAlmada, Marta
000107416 700__ $$aCosta, Elisio
000107416 700__ $$aGiardini, Anna
000107416 700__ $$aGil Peinado, María
000107416 700__ $$aMassot Mesquida, Mireia
000107416 700__ $$aMucherino, Sara
000107416 700__ $$aOrlando, Valentina
000107416 700__ $$aParra-Calderón, Carlos Luis
000107416 700__ $$aPepiol Salom, Enrique
000107416 700__ $$aKardas, Przemyslaw
000107416 700__ $$aVrijens, Bernard
000107416 7102_ $$11011$$2615$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Medic.Prevent.Salud Públ.
000107416 773__ $$g18, 9 (2021), 4872 [9 pp.]$$pInt. j. environ. res. public health$$tInternational journal of environmental research and public health$$x1661-7827
000107416 8564_ $$s607764$$uhttps://zaguan.unizar.es/record/107416/files/texto_completo.pdf$$yVersión publicada
000107416 8564_ $$s2794657$$uhttps://zaguan.unizar.es/record/107416/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000107416 909CO $$ooai:zaguan.unizar.es:107416$$particulos$$pdriver
000107416 951__ $$a2023-05-18-14:30:21
000107416 980__ $$aARTICLE